Join us on 28 May 2025 for an in-person panel discussion exploring how life sciences venture capital firms unlock biotech potential. This event collaboration between the University of Cambridge Judge Business School and Forbion, brings together leading voices from venture capital, biotech entrepreneurship, and institutional investment.
Through dynamic conversation and in-depth case studies, the panel will unpack the due diligence process from a VC lens, evaluate the implications of evolving syndication models, and explore why life sciences continue to out perform other VC areas of investment. Whether you are a biotech founder, investor, academic or policy expert, this event offers a timely look at the forces shaping the future of biotech innovation.
